10.1016/j.cell.2018.09.048 56 LincoffA
374 Exendin-4 has also been shown to stimulate osteoblast activity and mitigate bone loss in an ovariectomized mouse model
However, the decision requires careful individualized assessment, considering each medication's risk profile, potential interactions, and your complete medical history
And high patient out-of-pocket costs owing to lack of insurance coverage continues to be a substantial obstacle, limiting initial uptake and leading to discontinuation for some who do start
Yes, a health evaluation including a review of your medical history and relevant lab work is required before any GLP-1 prescription is issued at the Virginia Institute of Plastic Surgery
However, the lack of a placebo control group limits interpretation, as placebo responses in eating disorder trials can be substantial